Tresiba 100IU Flextouch is a long-acting analog of insulin used for the treatment of diabetes mellitus. Insulin is a natural substance produced by the pancreas which helps in utilizing glucose for energy production. Patients with diabetes mellitus may not be able to utilize glucose due to the insufficient production of insulin or due to the body’s inability to use insulin or both. This medicine helps in the utilization of glucose and controlling blood glucose levels in such patients. Patients are advised to follow a strict exercise and diet regimen along with this medicine to get the best possible effect.
Side effects of Tresiba 100IU
Major & minor side effects for Tresiba Flextouch
Decreased blood glucose levels
Abdominal and stomach pain
Tingling of hands or feet
Unusual weight gain or loss
Nausea and Vomiting
Uses of Tresiba 100IU Flextouch
What is it prescribed for?
Type I Diabetes mellitus
This medicine is used in the treatment of Type 1 Diabetes mellitus, a lifelong condition in which the pancreas does not produce sufficient insulin to control the blood sugar levels.
Type II Diabetes Mellitus
This medicine is used in the treatment of Type II Diabetes Mellitus, a lifelong condition in which the insulin produced by the body cannot be used properly by the cells to convert glucose into energy.
When not to use?
This medicine is not recommended for use in patients with a known allergy to insulin degludec or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients suffering from decreased blood sugar levels (hypoglycemia) since it may worsen the patient’s condition.
Warnings for special population
This medicine is not recommended for use in pregnant women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine. Breastfeeding women generally require lower doses of insulin.
Tresiba Flextouch is not recommended for the treatment of diabetic ketoacidosis due to the delayed onset of action. Alternative treatment options should be considered based on the clinical condition of the patient.
This medicine may cause serious and occasionally fatal hypersensitivity reactions (severe allergic reactions) including anaphylactic shock in some patients. Seek immediate medical intervention if any signs and symptoms of an allergic reaction such as skin rash, sore throat, difficulty breathing, swelling of the face, etc. occur. If an anaphylactic reaction occurs, the treatment should be discontinued immediately and appropriate corrective measures should be undertaken.
This medicine may cause hypoglycemia (low blood glucose levels) in some patients. This risk is especially higher in patients suffering from kidney diseases, malnourishment, pituitary gland diseases, etc. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be required based on the clinical condition. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels (hypoglycemia).
Hypokalemia (Decreased potassium levels)
This medicine should be used with caution in patients at risk of developing hypokalemia or patients suffering from hypokalemia since it may worsen the patient’s condition. Close monitoring of potassium levels, appropriate corrective measures, or dose adjustments may be required based on the clinical condition of the patient.
Use in children
This medicine is not recommended to use in children below 1 year of age since the safety and efficacy of use are not clinically established.
Subcutaneous use only
This medicine is meant for subcutaneous administration only. The long duration of action of this medicine is dependent on a subcutaneous administration. It should not be administered intravenously or intramuscularly.
Changing the type and brand of insulin
Transferring to a different brand or type of insulin should be done under strict medical supervision.
This medicine should be used with extreme caution in patients who are concomitantly taking PPAR-gamma agonists (Thiazolidinediones) due to the increased risk of fluid retention which may exacerbate to heart failure. Frequent clinical monitoring is advised in such patients. Report any unusual symptoms to the doctor on priority. Do not stop the use of any medicine without consulting your doctor.
If you miss a dose of this medicine, contact your doctor for further instructions. You should not use more than one dose in a 24-hour period unless specifically instructed by the doctor.
Seek immediate medical attention or contact the doctor if an overdose of this medicine is suspected. Hypoglycemia (low blood glucose levels) may occur in case of an overdose with symptoms such as extreme weakness, blurred vision, sweating, trouble speaking, tremors, stomach pain, confusion, etc. In cases of mild hypoglycemic episodes, oral glucose or sugary products can be used to avoid severe hypoglycemia.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of both hypoglycemia (low blood glucose levels) and hyperglycemia (high blood glucose levels) depending on the quantity and frequency of alcohol consumption. This may cause severe side effects such as dizziness, drowsiness, increased thirst, increased hunger, mood changes, extreme fatigue, etc.
Interaction with Medicine
This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition of the patient.
Caution is advised if this medicine is used in patients at an increased risk of developing hypokalemia or patients suffering from hypokalemia (decreased blood potassium levels) since it may worsen the patient’s condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
This medicine should be used with caution in patients with a history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be necessary based on the clinical condition of the patient.
Information not available.
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Carefully follow all the instructions given by your doctor. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor. Close monitoring of blood glucose levels and frequent follow-up visits with the doctor may be required based on the clinical condition. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed.